You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • SAT0153 Clinical Efficacy Rate of the Non-Specific Effect (The Placebo Effect) in the Tumour Necrosis Factor Inhibitors for Rheumatoid Arthritis Treatment After Methotrexate Failure: Meta-Analysis

Article info

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0153 Clinical Efficacy Rate of the Non-Specific Effect (The Placebo Effect) in the Tumour Necrosis Factor Inhibitors for Rheumatoid Arthritis Treatment After Methotrexate Failure: Meta-Analysis

Authors

Citation

Azaïs J, Barnetche T, Vergne Salle P, et al
SAT0153 Clinical Efficacy Rate of the Non-Specific Effect (The Placebo Effect) in the Tumour Necrosis Factor Inhibitors for Rheumatoid Arthritis Treatment After Methotrexate Failure: Meta-Analysis
Annals of the Rheumatic Diseases 2015;74:707.

Publication history

  • First published June 9, 2015.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions